申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
公开号:US20210363123A1
公开(公告)日:2021-11-25
Provided herein are inhibitors of SLC26A3, which is an anion (CV, HCO
3
, oxalate) exchanger expressed in intestinal epithelial cells. SLC26A3 inhibitors have potential utility for treatment of constipation including chronic idiopathic constipation (CIC), opioid-induced constipation (OIC), constipation-predominant irritable bowel syndrome (IBS-C), cystic fibrosis-associated constipation, meconium ileus, distal intestinal obstruction syndrome, calcium oxalate kidney stone disease, enteric hyperoxaluria and primary hyperoxalurias.